Answer:
<em>The correct option is A. Nucleotide sequence, human, hemoglobin</em>
Explanation:
If the segment of the DNA for the human gene is known then it will be very easy to find the gene on a database. The tags which should be used will be the nucleotide sequence, where the known sequence shall be mentioned.
Then we will choose the tag for the organism which is humans in this case. Then we will select the tag for the protein which is made by the nucleotide sequence, which is protein in this case. Hence, option A is the correct answer.
Explanation:
First do the Last, First, Then middle names of the author(s). Then the title of the article, then magazine. after that the date it was published and finally the page number the information was found on. example: Last, First Middle "title of article" title of magazine
Answer:
Amino acid
Explanation:
The basic building block of a protein is called an amino acid. There are 20 amino acids in the proteins you eat and in the proteins within your body, and they link together to form large protein molecules.
<h2>Issues with animal research in bred</h2>
Explanation:
- Since all animals are reared and brought up in a similar domain, they may contrast from animals reproduced in an alternate settlement Animal activist may think that its unscrupulous to utilize animals in look into Working with animals requires IRB conventions that protect the prosperity of the animals, making it difficult to play out certain examinations on them.
- Scientific researchers keep up that despite the fact that animal research, (as some other models in vitro or on the other hand human), doesn't generally convey ideal outcomes for human pertinence, it's still – in blend with important non-creature techniques - the essential method to do research to comprehend living systems and to give the most ideal affirmation of the impacts of new medicines preceding the primary clinical preliminaries in people.
- Clinical preliminaries are not ready to give results with 100% precision because of the huge inconstancy of the human population. The medicines improvement process including in silico, in vitro, pre-clinical (animals) and clinical (human) stages diminish the hazard for the Human population as a whole.
